Advertisement

Topics

Nimbus Therapeutics, LLC Company Profile

16:05 EDT 20th June 2019 | BioPortfolio

Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.


News Articles [879 Associated News Articles listed on BioPortfolio]

Former Nimbus Exec Rosana Kapeller Lands at GV

Rosana Kapeller, former chief scientific officer at Nimbus Therapeutics, is now entrepreneur-in-residence for life sciences at GV, according to an Endpoints News report. Kapeller co-founded Cambridge,...

Nimbus Picks Janssen’s Tummino for Chief Scientific Officer Post

Nimbus Therapeutics has appointed Peter Tummino to serve as its chief scientific officer. Tummino comes to the Cambridge, MA, company from Johnson & Johnson (NYSE: JNJ) subsidiary Janssen, where h...

A Decade of Discovery

This blog was written by Jeb Keiper, CEO of Nimbus Therapeutics LLC, as part of the From The Trenches feature of LifeSciVC. It is with great excitement that we at Nimbus are ringing in our 10th birthd...

Executives On The Move: Management Changes at UroGen and Nimbus

Elizabeth Barrett becomes the new CEO and President at urology therapy firm UroGen Pharma, and Nimbus Therapeutics promotes financial exec...   

#news #biotech Nimbus brings on Janssen discovery head as CSO with plans to expand its portfolio

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Nimbus brings on Janssen discovery head as CSO with plans to expand its portf...

Nimbus Therapeutics Strengthens Leadership Team

Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today announced the promotion of Holly Whittemore, C....

Nimbus Therapeutics Grows Scientific Team, Adding Leaders in Biology and Preclinical Development

Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today announced the addition of two experts in...

Nimbus Therapeutics Appoints Peter Tummino, Ph.D., as Chief Scientific Officer

Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today announced the appointment of Peter Tummi...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]

NA

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [451 Associated PubMed Articles listed on BioPortfolio]

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

CRISPR: a promising tool for lipid physiology and therapeutics.

The purpose is to review recent progress in applying the CRISPR/Cas9 system to lipid metabolism and therapeutics.

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro.

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.

Advancing Nucleic Acid Therapeutics by Setting Uniform Standards for Experimental Controls.

Clinical Trials [183 Associated Clinical Trials listed on BioPortfolio]

Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression

The objectives of this study are to evaluate the safety and efficacy of applying electrical stimulation on the Promontorium and the vicinity of the round window for the suppression of tinn...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1346 Associated Companies listed on BioPortfolio]

Nimbus Therapeutics

Nimbus Therapeutics harnesses the power of computational chemistry to design breakthroughs for the treatment of substantial and underserved human diseases. The company’s focu...

Nimbus Therapeutics, LLC

Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pi...

NIMBUS Biotechnology GmbH

Welcome to NIMBUS Biotechnology! NIMBUS Biotechnology is an ADME focused Biotech company. Transil ADME Assays are innovative screening tools giving access to some of the most important ADME parameter...

Nimbus Discovery LLC

Nimbus Discovery is applying advances in computer-based drug discovery to develop new medicines against important drug targets and thereby unlock fundamental biological pathways. ...

Nimbus Discovery, LLC

Nimbus Discovery, a biotechnology company, harnesses cutting-edge computational technologies to uncover breakthroughs in small molecule pharmacology. Nimbus focuses on medically i...

More Information about "Nimbus Therapeutics, LLC" on BioPortfolio

We have published hundreds of Nimbus Therapeutics, LLC news stories on BioPortfolio along with dozens of Nimbus Therapeutics, LLC Clinical Trials and PubMed Articles about Nimbus Therapeutics, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nimbus Therapeutics, LLC Companies in our database. You can also find out about relevant Nimbus Therapeutics, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record